Psychotic Disorders - Serbia | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$8.66m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.52%, resulting in a market volume of US$9.34m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$138.20 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Serbia is experiencing significant growth and development due to several key factors.

Customer preferences: In Serbia, there is a growing demand for effective treatments and therapies for psychotic disorders. Customers are increasingly seeking out medications and therapies that can help manage symptoms and improve quality of life. They are also looking for personalized treatment options that take into account their individual needs and preferences. Additionally, there is a growing interest in alternative and complementary therapies, such as cognitive-behavioral therapy and mindfulness-based interventions, which are gaining popularity among customers in Serbia.

Trends in the market: One of the key trends in the Psychotic Disorders market in Serbia is the increasing availability and accessibility of medications and therapies. Pharmaceutical companies are expanding their presence in the country, making a wider range of medications and treatments available to customers. This has led to increased competition in the market, driving innovation and the development of new and more effective treatments for psychotic disorders.Another trend is the growing emphasis on early intervention and prevention. There is a greater recognition of the importance of early detection and treatment of psychotic disorders in order to minimize the impact on individuals and society as a whole. As a result, there is a focus on raising awareness and improving access to early intervention programs and services in Serbia.

Local special circumstances: Serbia faces unique challenges in the Psychotic Disorders market. One of the main challenges is the limited resources and infrastructure for mental health services. There is a shortage of mental health professionals, particularly in rural areas, which can hinder access to timely and appropriate care for individuals with psychotic disorders. Additionally, there is a stigma associated with mental health issues in Serbian society, which can discourage individuals from seeking help and treatment.

Underlying macroeconomic factors: The growth and development of the Psychotic Disorders market in Serbia are influenced by several macroeconomic factors. The overall economic growth and stability in the country have contributed to increased healthcare spending, including investments in mental health services. Additionally, government initiatives and policies aimed at improving mental health services and reducing the stigma associated with mental illness have also played a role in driving the growth of the market.In conclusion, the Psychotic Disorders market in Serbia is experiencing significant growth and development due to increasing customer demand, expanding availability of medications and therapies, a focus on early intervention and prevention, as well as government initiatives to improve mental health services. However, the market still faces challenges such as limited resources and infrastructure, as well as societal stigma surrounding mental health issues.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.